ketotifen bipharma 0,25 mg/ml oogdruppels opl. verp. éénmalig gebr.
bipharma b.v. - ketotifenwaterstoffumaraat 0,345 mg/ml - eq. ketotifen 0,25 mg/ml - oogdruppels, oplossing in verpakking voor éénmalig gebruik - 0,25 mg/ml - ketotifenwaterstoffumaraat 0.345 mg/ml - ketotifen
ketotifen teva 1 mg/5 ml siroop
teva pharma belgium sa-nv - ketotifenwaterstoffumaraat 0,276 mg/ml - eq. ketotifen 0,201 mg/ml - siroop - 1 mg/5 ml - ketotifenwaterstoffumaraat 0.276 mg/ml - ketotifen
ketazed 0,25 mg/ml oogdruppels opl. druppelfl.
horus pharma - ketotifenwaterstoffumaraat 0,345 mg/ml - eq. ketotifen 0,25 mg/ml - oogdruppels, oplossing - 0,25 mg/ml - ketotifenwaterstoffumaraat 0.345 mg/ml - ketotifen
altriabak 0,25 mg/ml oogdruppels opl. druppelfl.
laboratoires théa - ketotifenwaterstoffumaraat 0,345 mg/ml - eq. ketotifen 0,25 mg/ml - oogdruppels, oplossing - 0,25 mg/ml - ketotifenwaterstoffumaraat 0.345 mg/ml - ketotifen
zaditen 1 mg harde caps.
alfasigma s.p.a. - ketotifenwaterstoffumaraat 1,38 mg - eq. ketotifen 1 mg - capsule, hard - 1 mg - ketotifenwaterstoffumaraat 1.38 mg - ketotifen
zaditen 1 mg/5 ml siroop
alfasigma s.p.a. - ketotifenwaterstoffumaraat 0,276 mg/ml - eq. ketotifen 0,2 mg/ml - siroop - 1 mg/5 ml - ketotifenwaterstoffumaraat 0.276 mg/ml - ketotifen
zaditen retard 2 mg tabl. verl. afgifte
alfasigma s.p.a. - ketotifenwaterstoffumaraat 2,75 mg - eq. ketotifen 2 mg - tablet met verlengde afgifte - 2 mg - ketotifenwaterstoffumaraat 2.75 mg - ketotifen
dimethyl fumarate mylan
mylan ireland limited - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumaraat - multiple sclerose, relapsing-remitting - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - dimethylfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).